OLYMVAX Competitors and Similar CompaniesClear all
OLYMVAX's competitors and similar companies include UCB and Genentech.
 OLYMVAX Chengdu Olymvax Biopharmaceuticals (成都欧林生物科技股份有限公司) is a biopharmaceutical company that produces and sells vaccines. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | |
Founding Date | Founding Date 2009 | Founding Date 1928 | Founding Date 1976 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Chengdu, CN HQ Chengdu, CN Chongqing, CN | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more |
Employees | Employees 470 | Employees 9,052 | Employees 18,077 |
Valuation ($) | Valuation ($) 592 m | Valuation ($) 34.3 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥694.1m (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥49.6m (FY, 2025) | Cost of goods €1.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥648.5m (FY, 2025) | Gross profit €7.2b (FY, 2025) | Gross profit N/A |
Net income | Net income ¥21.9m (FY, 2025) | Net income €1.6b (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyGenentech
HQ
South San Francisco, US
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View company